Profile cover photo
Profile photo
Exiqon
7 followers -
LNA™-enhanced products and services for RNA research
LNA™-enhanced products and services for RNA research

7 followers
About
Posts

Post has attachment
Public
Exiqon joined QIAGEN on 1 October 2017. We have worked around the clock to make the transition as seamless as possible. Now, as the year comes to an end, we are excited about the future and upcoming innovations. We invite you to discover the new us and unlock novel opportunities within the RNA universe.

All of us at Exiqon would like to wish you a peaceful, joyous and relaxing Holiday Season. May 2018 bring happiness, intriguing research questions, and successful experiments.

Thank you for your support and partnership.

Season's Greetings!
Your RNA Team
Photo
Add a comment...

Post has attachment
Add a comment...

Post has attachment
Add a comment...

Post has attachment
A fast and robust microRNA ISH protocol well-suited for clinical biomarker studies recently been published in Methods Mol Biol using DIG or FAM double-labeled microRNA-specific LNA™-enhanced detection probes in formalin-fixed, paraffin-embedded (FFPE) tissue sections. Check out the details:
Add a comment...

Post has attachment
Learn how a research team at the University of Greifswald overcome challenges of profiling plasma microRNAs in thousands of samples.
Their goal: to uncover signatures of disease phenotypes.
Add a comment...

Post has attachment
Add a comment...

Post has attachment
Serum microRNA biomarkers for early detection of ovarian cancer. Learn how scientists at the Dana Farber Cancer Institute, USA have identified microRNAs in serum indicative of ovarian cancer and want to develop a blood based test for ovarian cancer:
Add a comment...

Post has attachment
#Exosomes can be the key to access #microRNAs in #biofluids. Learn more and book a free consultation to discuss your service project: https://goo.gl/a5FGBx
Photo
Add a comment...

Post has attachment
TAmiRNA: “Our ultimate goal is to identify a signature of circulating microRNAs that is predictive of fracture-risk due to osteoporosis.” Read the interview with the co-founders of TAmiRNA and learn how they have developed a non-invasive serum microRNA test for osteoporosis, using Exiqon technology.
Add a comment...

Post has attachment
Add a comment...
Wait while more posts are being loaded